Transcutaneous Bilirubinometry and Phototherapy
ConditionNeonatal Hyperbilirubinemia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age0-2
SponsorPrincess Amalia Children's Clinic
About this trial
A randomized Controlled trial comparing the use of transcutaneous bilirubinometry to serum bilirubin measurements (via blooddraws = standard care) in neonates born after a gestational age \> 32 weeks and \< 15 days of age treated with Phototherapy for neonatal hyperbilrubinemia.
Eligibility criteria
Qualifiers
Neonates with indication for phototherapy for treatment of hyperbilirubinemia
Disqualifiers
skinlesions located on the sternum interfering with transcutaneous measurement
exchange transfusion
Trial design
Treatments tested in this trial
- Transcutaneous bilirubinometry
- Serum bilirubin
Treatment groups
130 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov